AR042175A1 - Formulacion para modular el metabolismo de la glucosa en animales domesticos - Google Patents

Formulacion para modular el metabolismo de la glucosa en animales domesticos

Info

Publication number
AR042175A1
AR042175A1 ARP030101917A ARP030101917A AR042175A1 AR 042175 A1 AR042175 A1 AR 042175A1 AR P030101917 A ARP030101917 A AR P030101917A AR P030101917 A ARP030101917 A AR P030101917A AR 042175 A1 AR042175 A1 AR 042175A1
Authority
AR
Argentina
Prior art keywords
formulation
glucose metabolism
domestic animals
modulate glucose
amounts
Prior art date
Application number
ARP030101917A
Other languages
English (en)
Inventor
Gregory Dean Sunvold
Michael Anthony Ceddia
Jacquie Rand
Original Assignee
Univ Queensland Dept Of Compan
Iams Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland Dept Of Compan, Iams Company filed Critical Univ Queensland Dept Of Compan
Publication of AR042175A1 publication Critical patent/AR042175A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pediatric Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Feed For Specific Animals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Formulación dietética que contiene cantidades moderadas de hasta 32% de carbohidrato y 17% de grasa, combinadas con cantidades mayores de 40% de proteína. Puede incluir vitaminas, minerales, fibras u otros nutrientes. Se usa para la fabricación de una formulación en forma de alimento útil para la prevención, modulación de síntomas y tratamiento del metabolismo anormal de la glucosa, resistencia a la insulina, diabetes, prediabetes, hipertrigliceridemia, hiperlipidemia y sus combinaciones o aumentar la longevidad en animales domésticos o de companía.
ARP030101917A 2002-05-30 2003-05-30 Formulacion para modular el metabolismo de la glucosa en animales domesticos AR042175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38423002P 2002-05-30 2002-05-30

Publications (1)

Publication Number Publication Date
AR042175A1 true AR042175A1 (es) 2005-06-15

Family

ID=29711997

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030101917A AR042175A1 (es) 2002-05-30 2003-05-30 Formulacion para modular el metabolismo de la glucosa en animales domesticos

Country Status (9)

Country Link
US (2) US8142810B2 (es)
EP (1) EP1511397A1 (es)
JP (1) JP2005527233A (es)
AR (1) AR042175A1 (es)
AU (1) AU2003232430A1 (es)
CA (1) CA2485194A1 (es)
MX (1) MXPA04011863A (es)
TW (1) TW200407084A (es)
WO (1) WO2003101224A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US7666459B2 (en) * 2001-09-12 2010-02-23 The Procter & Gamble Company Pet food compositions
GB2397485A (en) * 2002-12-20 2004-07-28 Mars Uk Ltd Cat food composition
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20090252834A1 (en) * 2004-05-10 2009-10-08 Michael Griffin Hayek Compositions comprising glucose anti-metabolites
US20050276896A1 (en) * 2004-06-14 2005-12-15 Sadek Nagwa Z Formulation providing a low carbohydrate cereal based system including a novel dough and a pizza crust or bread product having open cell structure
ES2458308T5 (es) * 2004-09-21 2020-08-18 Société des Produits Nestlé SA Control de peso mejorado en animales de compañía de avanzada edad
AR053805A1 (es) 2005-05-31 2007-05-23 Iams Company Bifidobacterias probioticas para felinos
AU2006253006B8 (en) 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
PL2124966T3 (pl) 2007-02-01 2016-01-29 Iams Europe B V Sposób zmniejszania reakcji zapalnej i stresu u ssaków za pomocą antymetabolitów glukozy, awokado lub ekstraktów awokado
US20090053357A1 (en) * 2007-05-08 2009-02-26 Cook David A Corn-based feed product
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
SG10201510640QA (en) 2009-10-26 2016-01-28 Hoffmann La Roche Method For The Production Of A Glycosylated Immunoglobulin
US20130116171A1 (en) 2010-04-16 2013-05-09 Salk Institute For Biological Studies Methods for treating metabolic disorders using fgf
US10674747B2 (en) 2012-12-14 2020-06-09 Hill's Pet Nutrition, Inc. Anti-aging foods for companion animals
CN103858820A (zh) * 2014-03-11 2014-06-18 广西大学 一种小型猪2型糖尿病模型的制备方法
US10613070B2 (en) 2014-09-30 2020-04-07 Mars, Incorporated Refusal-based methods of establishing a cat or dog food preference
KR20170081657A (ko) * 2014-11-03 2017-07-12 스쁘씨야리떼 뻬 프 기호성 건조 고양이 사료 및 그의 제조 방법
JP2018535964A (ja) 2015-10-30 2018-12-06 ソーク インスティテュート フォー バイオロジカル スタディーズ 線維芽細胞増殖因子（ｆｇｆ）１アナログによるステロイド誘導性高血糖の処置
GB201522296D0 (en) * 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat
JP2022511726A (ja) * 2018-12-13 2022-02-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物における脂肪酸化又はエネルギー消費又は満腹感を増加させる方法
MX2021005669A (es) * 2018-12-13 2021-06-08 Nestle Sa Metodos para mejorar la salud metabolica en un animal.
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
TWI846431B (zh) * 2023-04-19 2024-06-21 琳安健康科技股份有限公司 個人化飲食血糖代謝預測裝置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2947503A1 (de) 1979-11-24 1981-05-27 Schmidt, Frieda, 8800 Ansbach Medizinisch-diaetetisches produkt und verfahren zu seiner herstellung
US5051270A (en) 1988-02-03 1991-09-24 Otsuka Pharmaceutical Co., Ltd. High protein nutritive food and process for preparing same
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5866555A (en) * 1997-03-12 1999-02-02 Beth Israel Deaconess Medical Center Diabetic supplement bar
US5932258A (en) 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
DE69909298T2 (de) * 1998-09-02 2004-05-27 Heska Corp., Fort Collins Verfahren zur herstellung einer zusammensetzung zum schutz eines fleischfressenden haustieres gegen krankheiten des abnormalen kohlenhydrat-metabolismus
US6238708B1 (en) * 1999-02-23 2001-05-29 The Iams Company Composition and process for controlling glucose metabolism in companion animals by dietary starch
US6071544A (en) 1999-04-01 2000-06-06 The Iams Company Dietary compositions and method for promoting healthy weight loss cats
DE10034802A1 (de) 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
FR2819382B1 (fr) 2001-01-17 2004-12-24 Royal Canin Sa Aliment sec pour controler la surcharge ponderale et l'obesite des chiens

Also Published As

Publication number Publication date
MXPA04011863A (es) 2005-07-26
US8142810B2 (en) 2012-03-27
US20040001875A1 (en) 2004-01-01
US8529940B2 (en) 2013-09-10
AU2003232430A1 (en) 2003-12-19
EP1511397A1 (en) 2005-03-09
TW200407084A (en) 2004-05-16
JP2005527233A (ja) 2005-09-15
WO2003101224A1 (en) 2003-12-11
US20120164265A1 (en) 2012-06-28
CA2485194A1 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
AR042175A1 (es) Formulacion para modular el metabolismo de la glucosa en animales domesticos
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
MY150595A (en) Nutritional composition to promote healthy development and growth
ES2173372T3 (es) Comprimidos multicapa que contienen microorganismos probioticos, como por ejemplo latobacilos o bifidobacterias.
CY1113183T1 (el) Χρηση νατριουριτικου πεπτιδιου για θεραπεια καρδιακης ανεπαρκειας
ES2659353T3 (es) Métodos y formulaciones nutricionales para aumentar la eficacia y reducir los efectos secundarios del tratamiento del cáncer
ES2175442T3 (es) Composiciones de carbohidratos de plantas como complementos dieteticos
ATE442050T1 (de) Nahrungsergänzungsmittel oder functional food enthaltend íl-kombination
AR025617A1 (es) Metodo para mejorar la condicion de mascotas anosas y un alimento para mascotas anosas de aplicacion en dicho metodo
WO2009013596A3 (en) Fortification of nutritional products with olive extracts containing hydroxytyrosol and hydroxytyrosol fortified nutritional products
MX2008004734A (es) Composicion rica en leucina.
PT923315E (pt) Formula nutricional para pacientes com fenilcetonuria
CL2014001937A1 (es) Uso de bacterias de grado alimenticio de precencia natural productora de ácido siálico o por lo menos una fracción de la misma que contiene ácido siálico que sirve para reforzar un alimento con ácido siálico; alimento reforzado con ácido siálico (divisional de la solicitud 1055-2011)
TR201903494T4 (tr) Sakkarit oligomerleri içeren besin ürünleri.
DE60231985D1 (de) Zusammensetzungen enthaltend zuckerrüben pektin und carotinoide
CO6160277A2 (es) Alimentacion de larga duracion -mayores de edad
CL2023002451A1 (es) Composiciones y métodos que usan una combinación de oleuropeína y vitamina b6
CL2023002452A1 (es) Composiciones y métodos que usan una combinación de oleuropeína y magnesio
ES2195902T3 (es) Composicion que comprende esfingomielinasa alcalina para uso como preparacion dietetica, complemento alimenticio o producto farmaceutico.
ES2144288T3 (es) Carne vegetal.
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
ATE258435T1 (de) Pinolensäure gegen diabetes
BR0109412A (pt) Beta-glicanos de fungos filamentosos
CL2009001087A1 (es) Mezcla de hidratos de carbono para su utilizacion en un producto alimenticio destinado a la nutricion enteral u oral que comprende almidon resistente de tipo iv, maltodextrina de baja dextrosa equivalente de=5-8, inulina y celulosa; producto alimenticio que la contiene; y uso de la mezcla de hidratos de carbono.
ATE308989T1 (de) Zubereitung für oral zu verabreichende nahrungsergänzungs- und/oder arznelmittel in form von tabletten

Legal Events

Date Code Title Description
FC Refusal